Clinical Trial Update: A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise [Phase 3]

View source ↗

Summary

A Phase 3 trial update of dapagliflozin (BMS-512148) in adults with type 2 diabetes not adequately controlled by diet and exercise completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2014-05-14